Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

INSULIN PUMPS (EXTERNAL) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 16 companies including many key and niche players such as Animas Corporation, Debiotech S.A., F. D. Medical Industries Ltd., F.Hoffmann-La Roche, Ltd., Insulet Corporation, Medtronic Diabetes, Nipro Diabetes Systems, Royal Fornia Medical Equipment Co. Ltd., Sooil Development Co. Ltd., Valeritas Inc., and Ypsomed Holding AG. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Code : MCP-1511
Price : $4950
Companies : 16
Pages : 197
Date : October, 2012
Market Data Tables : 63

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  INSULIN PUMPS (EXTERNAL) (Complete Report) Pages : 197   | $4950
 
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS  
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
II. EXECUTIVE SUMMARY49$2650
  1. INDUSTRY OVERVIEW.....II-12 $200  
   Insulin Pumps: Current & Future Analysis.....II-1
The United States – The Largest Market for External Insulin Pumps.....II-1
1$100
   European Market Characterized by Less Pump Users.....II-2
Increasing Diabetes Prevalence – A Major Growth Propeller for Insulin Pumps.....II-2
1$100
  2. MARKET TRENDS AND ISSUES.....II-35 $395  
   Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market.....II-3
Innovative Features Spruce Up the Market for Insulin Pumps.....II-3
1$100
   Patch Pumps Gain Manufacturer Attention.....II-41$100
   Next Generation Insulin Pumps.....II-5
Combination Products in Rage.....II-5
1$100
   ICR: A Key Factor to Success.....II-6
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-6
Customer Satisfaction: Crucial to Stay Competitive.....II-6
Insulin Pump Training - Not Receiving Adequate Attention.....II-6
1$100
   Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-7
Competition from Other Insulin Delivery Technologies Continues.....II-7
Teenagers Outdo Adults in Controlling Diabetes.....II-7
Undiagnosed Diabetes – A Key Challenge.....II-7
1$100
  3. COMPETITIVE ANALYSIS.....II-84 $595  
   Competition Gears Up With Companies Focusing on Next Generation Products.....II-8 1$100
   Table 1: Leading Players In The Global Insulin Pumps Market (2011): Percentage Breakdown Of Sales for Medtronic, Roche, Insulet And Others (includes corresponding Graph/Chart).....II-91$350
   Comparison Of Available Insulin Pump Systems By Manufacturer.....II-101$100
   Competition In The Patch Pumps Market.....II-11
Tough Ground For New Entrants.....II-11
1$100
  4. DIABETES- INCIDENCE AND PREVALENCE.....II-127 $1450  
   Diabetes- Incidence and Prevalence.....II-12 1$100
   Table 2: Diabetic Population by Region (2011 & 2030) (includes corresponding Graph/Chart).....II-131$350
   Table 3: Top Ten Countries by Diabetic Population : 2011 (includes corresponding Graph/Chart).....II-14

Table 4: Top Ten Countries by Diabetic Population : 2030 (includes corresponding Graph/Chart).....II-14
Diabetes – Assessing The Economic Burden.....II-14
1$350
   Table 5: Diabetes Related Healthcare Expenditure by Region: 2011 (in US$ billion) (includes corresponding Graph/Chart).....II-15
Diabetes Mellitus Cases Worldwide – A Demographic Analysis by Geographic
  Region.....II-15
North America.....II-15
1$350
   Table 6: Prevalence of Diabetes Mellitus in North America (2011 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart).....II-16
Europe.....II-16
1$350
   Table 7: Prevalence of Diabetes Mellitus in Europe (2010 & 2030): Breakdown by Country, Age Group, and Gender (In Thousand People & %).....II-171$350
   Asia-Pacific.....II-18
South & Central America.....II-18
1$100
  5. DIABETES & INSULIN – AN ABSTRACT.....II-196 $595  
   Diabetes - A Fatal Disease.....II-19
Risk Factors for Diabetes.....II-19
Types of Diabetes.....II-19
1$100
   Long Term Complications of Diabetes.....II-20
Testing Sugar Levels: Easy and Accurate.....II-20
Insulin .....II-20
Pancreas: The Main Source of Insulin in Human Body.....II-20
Types of Insulin.....II-20
1$100
   Types of Insulin & Onset of Action.....II-21
Goal of Insulin Therapy.....II-21
Insulin Delivery Systems.....II-21
1$100
   Table 8: Leading Players in the Global Insulin Delivery Devices Market (2010): Percentage Breakdown by Market Share for Medtronic, Novo Nordisk, Sanofi and Others (includes corresponding Graph/Chart).....II-22
a. Syringes.....II-22
1$350
   b. Insulin Pens.....II-23
c. Jet Injectors.....II-23
d. Tablets.....II-23
1$100
   e. External Insulin Pumps.....II-24
f. Artificial Pancreas.....II-24
Insulin Delivery Technologies.....II-24
1$100
  6. PRODUCT OVERVIEW.....II-256 $595  
   Evolution of Insulin Pumps.....II-25
Insulin Pump - A Replica of Pancreas.....II-25
Advantages.....II-25
More Accurate and Consistent.....II-25
1$100
   Enhances Blood Sugar Control in Pediatric Patients.....II-26
Adjusting Time Zones While Traveling.....II-26
Improves Quality of Life.....II-26
Patient Convenience.....II-26
1$100
   Components of Insulin Pump.....II-27
How Does an Insulin Pump Work?.....II-27
Insulin Pump Delivery Rates.....II-27
1$100
   Guidelines for Insulin Pump Usage.....II-28
Disadvantages/Risks Involved in the Usage of Insulin Pumps.....II-28
1$100
   High Cost.....II-29
High Involvement.....II-29
Diabetic Ketoacidosis Risk.....II-29
Glucose Testing at Regular Intervals.....II-29
Regular Rotation of Infusion Set.....II-29
Carrying Back-up Kit.....II-29
1$100
   Regular Refilling of Pump.....II-30
Lantus: A Threat to Insulin Pump Manufacturers.....II-30
Centers for Medicare & Medicaid Services (CMS): Funding Organizations.....II-30
1$100
  7. PRODUCT INNOVATIONS/INTRODUCTIONS LIFESCAN ACQUIRES CALIBRA MEDICAL.....II-313 $295  
   Tandem Diabetes to Launch New Insulin Pump – t:slim.....II-31
Cellnovo Obtains CE Mark for Patch Pump.....II-31
Asante Receives 510 (K) Approval.....II-31
Spring-Set Health Solutions Obtains FDA Approval.....II-31
JDRF Develops Novel Technology for Type 1 Diabetes.....II-31
1$100
   Johnson & Johnson Medical India to Unveil Insulin Pumps in India.....II-32
Debiotech and STMicroelectronics Introduce First Prototype of a Miniaturized,
  Disposable Insulin Nanopump.....II-32
ROCHE Launches Accu-Chek Spirit.....II-32
Smith Medical Launches Cozmo in China.....II-32
1$100
   Industrial Scholar Devises Wristwatch Insulin Pump.....II-33
Medtronic Unveils Arabic Language Insulin Pump.....II-33
Medtronic Launches New Diabetes Monitoring System.....II-33
1$100
  8. RECENT INDUSTRY ACTIVITY.....II-344 $395  
   LifeScan Acquires Calibra Medical.....II-34
Roche’s Diagnostic Division to Close Down Medingo.....II-34
Spring Health Enters into Distribution Agreement with Solara.....II-34
Spring Health Solutions and Better Living Now Ink Agreement.....II-34
Mediq Takes Over Diabetes Specialty Center (Sweden/US).....II-34
1$100
   Indutrade to Acquire Rubin Medical.....II-35
Insulet Acquires Neighborhood Diabetes.....II-35
Medtronic and Bayer HealthCare Expand Collaboration to Cover US Market.....II-35
JDRF Enters into Partnership with Animas.....II-35
1$100
   JDRF Collaborates with BD.....II-36
Nilimedix Inks Strategic Distribution Agreement with Sinopharm.....II-36
Roche Takes Over Medingo.....II-36
1$100
   Insulet Inks Exclusive Distribution Agreement with Ypsomed.....II-371$100
  9. CORPORATE ACTIVITY IN THE RECENT PAST – A PERSPECTIVE BUILDER.....II-385 $395  
   NiliMedix Obtains CE Mark Certification for NiliPatch Disposable Insulin Pump.....II-38
Medingo Obtains FDA Approval for Marketing Insulin Micropump.....II-38
Eli Lilly and Medtronic Enter into a Strategic Marketing Alliance.....II-38
Medtronic Acquires Certain Assets from PreciSense.....II-38
1$100
   Insulet Wins CE Mark Approval for OmniPod® Insulin Management System.....II-39
DexCom and Animas Amend Insulin Pump Joint Development Deal.....II-39
Medtronic Inaugurates Diabetes Therapy Management and Education Center.....II-39
Smiths Medical Ceases Insulin Pumps Sale, Exits Diabetes Business.....II-39
1$100
   Alere Medical Acquires Matria Healthcare.....II-40
Smiths Medical Acquires Zhejiang Zheda Medical Instrument.....II-40
Animas Partners with DexCom.....II-40
Animas Recalls Insulin Pumps with Faulty Battery Cap.....II-40
VitalCare Announces Launch of Diabetes Treatment Centers Across the US.....II-40
1$100
   Novo Nordisk Receives FDA Approval for Pediatric Application of NovoLog®.....II-41
Insulet Inks Agreement with DexCom.....II-41
Medtronic Partners with LifeScan.....II-41
Phluid Corporation Inks Agreement with Syprosoft.....II-41
Insulet Partners with Flextronics.....II-41
Medco Acquires PolyMedica.....II-41
1$100
   Debiotech Inks Agreement with STMicroelectronics.....II-42
NiliMedix Seeks FDA Approval.....II-42
NiliMedix Attains CE Approval.....II-42
NationsHealth Pockets Diabetes Care & Education.....II-42
SpectRx, Inc. Divests Insulin Pump Business.....II-42
1$100
  10. FOCUS ON SELECT KEY PLAYERS.....II-434 $395  
   Animas Corp. (USA).....II-43
Debiotech S.A. (Switzerland).....II-43
D. Medical Industries Ltd. (Israel).....II-43
1$100
   F. Hoffmann-La Roche, Ltd. (Switzerland).....II-44
Insulet Corporation (USA).....II-44
1$100
   Medtronic Diabetes (USA).....II-45
Nipro Diabetes Systems (USA).....II-45
Royal Fornia Medical Equipment Co. Ltd. (China).....II-45
1$100
   Sooil Development Co. Ltd. (Korea).....II-46
Valeritas Inc. (US).....II-46
Ypsomed Holding AG (Switzerland).....II-46
1$100
  11. GLOBAL MARKET PERSPECTIVE.....II-47   
   Table 9: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-471$350
   Table 10: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-481$350
   Table 11: World 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Europe, and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-491$350
III. MARKET42$2350
  1. THE UNITED STATES.....III-113 $1450  
   A. Market Analysis.....III-1
External Insulin Pumps: A Key Mechanism for Insulin Delivery.....III-1
Table 12: Penetration of Insulin Pumps for Treating Type I Diabetics in the US (2005-2015) (includes corresponding Graph/Chart).....III-1
1$200
   Surging Diabetic Population Keeps Demand Ticking for Insulin Pumps.....III-2
Table 13: Diabetes Population in the US (2009-2015): Percentage of US Population with Diabetes and Undiagnosed Diabetes (includes corresponding Graph/Chart).....III-2
1$200
   Table 14: Type I Diabetics in the US (2010 & 2012E): Percentage Share Breakdown of Treatment Type (includes corresponding Graph/Chart).....III-3

Table 15: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-3
1$200
   Table 16: US Diabetes Prevalence (in Million) for 2010-2015 (includes corresponding Graph/Chart).....III-4

Table 17: Diabetes Prevalence in the US by Diabetes Type: 2011 (includes corresponding Graph/Chart).....III-4
1$200
   Table 18: Type 1 Diabetes Patient Population in the US (2009-2015) (includes corresponding Graph/Chart).....III-5

Table 19: Type II Diabetes Patient Population in the US (2009-2015) (includes corresponding Graph/Chart).....III-5
1$200
   Competitive Scenario.....III-6
Table 20: Leading Players in the US Insulin Pumps Market (2011): Percentage Breakdown by Market Share for Medtronic, Johnson and Johnson, Roche, Insulet and Others (includes corresponding Graph/Chart).....III-6
Major Insulin Pump Systems: A Comparison.....III-6
Major Insulin Pumps in Development Stages.....III-6
1$200
   Regulatory Scenario.....III-7
FDA Announces a New Mandate for Manufacturing Companies.....III-7
Strategic Corporate Developments.....III-7
3$225
   Key Players.....III-102$150
   B. Market Analytics.....III-12
Table 21: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-12
1$200
   Table 22: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-131$200
  2. EUROPE.....III-148 $950  
   A. Market Analysis.....III-14
Diabetes Prevalence in Europe.....III-14
1$75
   Table 23: Percentage of Population with Diabetes and Prevalence of Diabetes in the EU (2009-2015) (includes corresponding Graph/Chart).....III-15
Though Late, Insulin Pump Starts Gaining Favor Among Europeans.....III-15
1$200
   Strategic Corporate Developments.....III-161$75
   Key Players.....III-172$150
   B. Market Analytics.....III-19
Table 24: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-19
1$200
   Table 25: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-201$200
   Table 26: European 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-211$200
  2a. FRANCE.....III-222 $395  
   Market Analysis.....III-22
Table 27: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-22
1$200
   Table 28: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-231$200
  2b. GERMANY.....III-242 $395  
   Market Analysis.....III-24
Table 29: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-24
1$200
   Table 30: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-251$200
  2c. ITALY.....III-262 $395  
   Market Analysis.....III-26
Table 31: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-26
1$200
   Table 32: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-271$200
  2d. THE UNITED KINGDOM.....III-283 $395  
   A. Market Analysis.....III-28
Current and Future Analysis.....III-28
INPUT (The Insulin Pump Therapy Group).....III-28
NICE (National Institute of Clinical Excellence).....III-28
1$75
   B. Market Analytics.....III-29
Table 33: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-29
1$200
   Table 34: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-301$200
  2e. SPAIN.....III-312 $395  
   Market Analysis.....III-31
Table 35: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-31
1$200
   Table 36: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-321$200
  2f. REST OF EUROPE.....III-333 $395  
   A. Market Analysis.....III-33
Current and Future Analysis.....III-33
Russia.....III-33
1$75
   B. Market Analytics.....III-34
Table 37: Rest of Europe Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-34
1$200
   Table 38: Rest of Europe Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-351$200
  3. REST OF WORLD.....III-367 $395  
   A. Market Analysis.....III-36
Current and Future Analysis.....III-36
Review of Select Countries/Regions.....III-36
India.....III-36
Diabetes Scenario.....III-36
Insulin Pumps Gather Momentum.....III-36
1$75
   Medtronic: The Undisputed Market Leader.....III-37
China.....III-37
Overview.....III-37
Competition.....III-37
1$75
   Brazil.....III-38
UAE.....III-38
Demand for Insulin Pumps Grows Strongly in the UAE.....III-38
Product Launch.....III-38
Strategic Corporate Developments.....III-38
1$75
   Key Players.....III-392$150
   B. Market Analytics.....III-41
Table 39: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-41
1$200
   Table 40: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-421$200
IV. COMPETITIVE LANDSCAPE 96$995
  
Total Companies Profiled: 16 (including Divisions/Subsidiaries - 21)

Region/Country                 Players

The United States                 10  
Europe                             5
     The United Kingdom            1
     Rest of Europe                4
Asia-Pacific (Excluding Japan)     6
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign